Oral Nutrition During Continuous Albuterol for Pediatric Critical Asthma: A Matched Cohort Study.

IF 1.3 Q3 PEDIATRICS
Maya Antionette Root, Carolyn Maria Ibrahim Pavlich, Anthony Alexander Sochet, Alexa Rae Roberts, Brett Walter Russi
{"title":"Oral Nutrition During Continuous Albuterol for Pediatric Critical Asthma: A Matched Cohort Study.","authors":"Maya Antionette Root, Carolyn Maria Ibrahim Pavlich, Anthony Alexander Sochet, Alexa Rae Roberts, Brett Walter Russi","doi":"10.5223/pghn.2024.27.6.364","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>The practice of withholding oral nutrition for children hospitalized for critical asthma receiving continuous albuterol is not evidence based. We sought to characterize oral nutrition practices in this population and estimate the frequency of aspiration-related respiratory failure.</p><p><strong>Methods: </strong>We performed a single-center retrospective, matched cohort study of children 3-17 years of age admitted to a pediatric intensive care unit from Oct 2020 to May 2023 for critical asthma receiving continuous albuterol. Cases provided oral nutrition were matched 1:2 to controls withheld nutrition by age and National Heart Lung and Blood Institute asthma severity classification. The primary outcome was aspiration-related respiratory failure defined as any respiratory support escalation following observed aspiration. Descriptive data included demographics, anthropometrics, pediatric asthma severity scores, adjunct asthma interventions, continuous albuterol duration, mortality, and length of stay.</p><p><strong>Results: </strong>Of 36 cases and 72 matched controls, the mean age was 9.1±3.9 years and 66.7% had moderate-severe persistent asthma. Cases and controls had comparable anthropometrics and admission pediatric asthma severity scores. No aspiration-related respiratory failure events were observed even among those receiving nutrition concurrent to noninvasive ventilation. Compared to controls, cases experienced a longer continuous albuterol duration (median: 1.1 [interquartile range: 0.7-1.8] versus 0.7 [interquartile range: 0.3-1.3] days, <i>p</i><0.001). No differences in length of stay, adjunct interventions, endotracheal intubation rates, and mortality were observed between cases and controls.</p><p><strong>Conclusion: </strong>For children hospitalized for critical asthma, oral nutrition during continuous nebulized albuterol appeared well tolerated. While prospective validation is required, the practice of withholding oral nutrition for continuous albuterol administration may be unwarranted.</p>","PeriodicalId":19989,"journal":{"name":"Pediatric Gastroenterology, Hepatology & Nutrition","volume":"27 6","pages":"364-371"},"PeriodicalIF":1.3000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11570357/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Gastroenterology, Hepatology & Nutrition","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5223/pghn.2024.27.6.364","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/5 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: The practice of withholding oral nutrition for children hospitalized for critical asthma receiving continuous albuterol is not evidence based. We sought to characterize oral nutrition practices in this population and estimate the frequency of aspiration-related respiratory failure.

Methods: We performed a single-center retrospective, matched cohort study of children 3-17 years of age admitted to a pediatric intensive care unit from Oct 2020 to May 2023 for critical asthma receiving continuous albuterol. Cases provided oral nutrition were matched 1:2 to controls withheld nutrition by age and National Heart Lung and Blood Institute asthma severity classification. The primary outcome was aspiration-related respiratory failure defined as any respiratory support escalation following observed aspiration. Descriptive data included demographics, anthropometrics, pediatric asthma severity scores, adjunct asthma interventions, continuous albuterol duration, mortality, and length of stay.

Results: Of 36 cases and 72 matched controls, the mean age was 9.1±3.9 years and 66.7% had moderate-severe persistent asthma. Cases and controls had comparable anthropometrics and admission pediatric asthma severity scores. No aspiration-related respiratory failure events were observed even among those receiving nutrition concurrent to noninvasive ventilation. Compared to controls, cases experienced a longer continuous albuterol duration (median: 1.1 [interquartile range: 0.7-1.8] versus 0.7 [interquartile range: 0.3-1.3] days, p<0.001). No differences in length of stay, adjunct interventions, endotracheal intubation rates, and mortality were observed between cases and controls.

Conclusion: For children hospitalized for critical asthma, oral nutrition during continuous nebulized albuterol appeared well tolerated. While prospective validation is required, the practice of withholding oral nutrition for continuous albuterol administration may be unwarranted.

小儿重症哮喘患者在持续服用阿布特罗期间的口服营养:匹配队列研究
目的:对于因重症哮喘住院并持续服用沙丁胺醇的儿童,暂停口服营养的做法并无证据支持。我们试图描述这一人群的口服营养做法,并估计与吸入相关的呼吸衰竭的发生频率:我们对 2020 年 10 月至 2023 年 5 月期间因重症哮喘连续服用沙丁胺醇而入住儿科重症监护病房的 3-17 岁儿童进行了一项单中心回顾性匹配队列研究。提供口服营养的病例与不提供营养的对照组按年龄和美国国家心肺血液研究所哮喘严重程度分类进行了 1:2 匹配。主要结果是吸入相关的呼吸衰竭,定义为观察到吸入后呼吸支持的任何升级。描述性数据包括人口统计学、人体测量学、小儿哮喘严重程度评分、辅助哮喘干预措施、连续使用沙丁胺醇时间、死亡率和住院时间:在 36 例病例和 72 例匹配对照中,平均年龄为(9.1±3.9)岁,66.7% 患有中度-重度持续性哮喘。病例和对照组的人体测量和入院时小儿哮喘严重程度评分相当。即使在接受营养和无创通气的同时,也没有观察到与吸入相关的呼吸衰竭事件。与对照组相比,病例持续服用沙丁胺醇的时间更长(中位数:1.1[四分位数]):1.1天[四分位数间距:0.7-1.8]对0.7天[四分位数间距:0.3-1.3],P 结论:对于因哮喘而住院的危重症儿童来说,持续使用阿布特罗的时间更长:对于因危重哮喘住院的儿童来说,在持续雾化吸入沙丁胺醇期间口服营养似乎耐受性良好。虽然需要进行前瞻性验证,但在连续雾化吸入阿布特罗期间暂停口服营养的做法可能是不正确的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.90
自引率
0.00%
发文量
43
期刊介绍: Pediatric Gastroenterology, Hepatology and Nutrition (Pediatr Gastroenterol Hepatol Nutr), an official journal of The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition, is issued bimonthly and published in English. The aim of Pediatr Gastroenterol Hepatol Nutr is to advance scientific knowledge and promote child healthcare by publishing high-quality empirical and theoretical studies and providing a recently updated knowledge to those practitioners and scholars in the field of pediatric gastroenterology, hepatology and nutrition. Pediatr Gastroenterol Hepatol Nutr publishes review articles, original articles, and case reports. All of the submitted papers are peer-reviewed. The journal covers basic and clinical researches on molecular and cellular biology, pathophysiology, epidemiology, diagnosis, and treatment of all aspects of pediatric gastrointestinal diseases and nutritional health problems.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信